High plasma apoB-containing lipoprotein (B-lp) levels enhance the risk for atherosclerosis. Our long-term goal is to explain molecular mechanisms of B-lp biosynthesis to find novel ways of reducing their concentrations. Previously, we described apoB-dependent and -independent pathways for free and esterified cholesterol transport by the intestine and defined the roles of MTP, ABCA1, ACAT2, apoAI, and apoAIV in these pathways. Concurrently, we observed that MTP-deficient abetalipoproteinemia patients and mice deficient in hepatic and intestinal MTP (L,I-Mttp-/-) have markedly lower plasma ceramide and sphingomyelin levels compared with controls but have normal hexosylceramide and lactosylceramide. Moreover, hepatic ABCA1 deficiency in mice and total deficiency in Tangier patients significantly reduced plasma sphingomyelin and hexosylceramide with no effect on lactosylceramide. Hence, we hypothesize that (1) MTP and ABCA1 are the major determinants of plasma ceramide and sphingomyelin; (2) ceramide secretion depends on MTP-mediated B-lp assembly; and (3) sphingomyelin transport involves both MTP- and ABCA1-dependent pathways.
Aim 1 : To determine the role of hepatic and intestinal MTP and ABCA1 in the control of plasma and tissue sphingolipids, we will use mice deficient in one or both of these genes in specific tissues. We will (1) measure total and individual species of ceramide, sphingomyelin, hexosylceramide, and lactosylceramide in the plasma, liver, and intestine of fed and fasted male L-Mttp-/- and I-Mttp-/- mice; (2) quantify these lipids in the plasma, liver, and intestine of fed and fasted Abca1-/-, L-Abca1-/-, and I-Abca1-/- mice; and (3) evaluate tissue-specific contributions of both MTP and ABCA1 using I-Mttp-/-;I-Abca1-/- and L-Mttp-/-;L-Abca1-/- double knockout mice.
Aim 2 : To explain biochemical and molecular mechanisms of sphingolipid transport to the plasma, we will (1) determine whether MTP is required for ceramide and sphingomyelin secretion; (2) find out if their secretion with B-lp is regulated by different faty acids that regulate B-lp secretion and ceramide synthesis; (3) ascertain if MTP transfers these lipids; and (4) elucidate mechanisms by which ABCA1 transports sphingolipids and study regulation of their secretion with HDL by liver X receptor (LXR) using agonists and Lxr deficient mice.
Aim 3 : To examine the role of human MTP and ABCA1 in sphingolipid transport, we will (1) study their role in the secretion of sphingolipids using human liver and intestinal cells; and (2) analyze the regulation of their secretion with B-lp and HDL by fatty acids and LXR. We expect these studies to (1) establish that sphingolipid transport involves different mechanisms; (2) show that MTP and ABCA1 are the major determinants of plasma sphingolipids; and (3) quantify the contributions of intestinal and hepatic B-lps and HDL to plasma sphingolipids. It is likely that lipoprotein-mediated sphingomyelin transport helps to maintain plasma membrane integrity of other tissues and ceramide transport protects the liver and intestine from ceramide toxicity.

Public Health Relevance

In the previous funding cycle, we illustrated mechanisms involved in the absorption and transport of free and esterified cholesterol. In this grant, we propose to delineate mechanisms involved and roles played by MTP and ABCA1 in the absorption and transport of ceramide and sphingomyelin with B-lp and HDL. These studies will provide novel information about the role of hepatic and intestinal MTP and ABCA1 in the regulation of plasma and tissue sphingolipids.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56DK046900-17A1
Application #
9036687
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Maruvada, Padma
Project Start
1995-01-01
Project End
2016-03-31
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
17
Fiscal Year
2015
Total Cost
$150,001
Indirect Cost
$56,905
Name
Suny Downstate Medical Center
Department
Neurology
Type
Schools of Medicine
DUNS #
040796328
City
Brooklyn
State
NY
Country
United States
Zip Code
11203
Sirwi, Alaa; Hussain, M Mahmood (2018) Lipid transfer proteins in the assembly of apoB-containing lipoproteins. J Lipid Res 59:1094-1102
Pan, Xiaoyue; Schwartz, Gary J; Hussain, M Mahmood (2018) Oleoylethanolamide differentially regulates glycerolipid synthesis and lipoprotein secretion in intestine and liver. J Lipid Res 59:2349-2359
Irani, Sara; Iqbal, Jahangir; Antoni, W James et al. (2018) microRNA-30c reduces plasma cholesterol in homozygous familial hypercholesterolemic and type 2 diabetic mouse models. J Lipid Res 59:144-154
Scerbo, Diego; Son, Ni-Huiping; Sirwi, Alaa et al. (2017) Kidney triglyceride accumulation in the fasted mouse is dependent upon serum free fatty acids. J Lipid Res 58:1132-1142
Zhou, Liye; Hussain, M Mahmood (2017) Human MicroRNA-548p Decreases Hepatic Apolipoprotein B Secretion and Lipid Synthesis. Arterioscler Thromb Vasc Biol 37:786-793
Iqbal, Jahangir; Walsh, Meghan T; Hammad, Samar M et al. (2017) Sphingolipids and Lipoproteins in Health and Metabolic Disorders. Trends Endocrinol Metab 28:506-518
Irani, Sara; Pan, Xiaoyue; Peck, Bailey C E et al. (2016) MicroRNA-30c Mimic Mitigates Hypercholesterolemia and Atherosclerosis in Mice. J Biol Chem 291:18397-409
Khalifeh-Soltani, Amin; Gupta, Deepti; Ha, Arnold et al. (2016) Mfge8 regulates enterocyte lipid storage by promoting enterocyte triglyceride hydrolase activity. JCI Insight 1:e87418
Hsieh, Joanne; Koseki, Masahiro; Molusky, Matthew M et al. (2016) TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis. Nature 535:303-7
Walsh, Meghan T; Iqbal, Jahangir; Josekutty, Joby et al. (2015) Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal ?-Barrel in Microsomal Triglyceride Transfer Protein Function. Circ Cardiovasc Genet 8:677-87

Showing the most recent 10 out of 27 publications